查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1944464

全球臨床前影像市場：產業分析、市場規模、佔有率及預測（按產品類型、模式、應用、最終用戶、國家和地區分類）（2025-2032 年）

Preclinical Imaging Market, By Product Type, By Modality, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 348 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，臨床前影像市場規模將達到 9.9598 億美元，從 2025 年到 2032 年，複合年成長率將達到 5.54%。

臨床前影像市場涵蓋用於在人體試驗前，利用活體動物模型研究疾病和藥物療效的設備、造影劑和軟體。這些工具能夠對腫瘤、器官和生物活性進行重複、非侵入性的長期追蹤，因此對早期藥物發現至關重要，有助於快速、準確地做出決策。常用的影像技術包括用於詳細觀察解剖結構的微型CT和微型MRI，用於功能和分子訊號分析的PET和SPECT，以及用於使用螢光和生物發光探針進行快速篩檢的光學成像。許多實驗室正在結合多種技術來提高研究品質。市場需求主要來自腫瘤學、神經病學和感染疾病研究等領域，以及生物製藥和先進治療方法的發展，這些都需要更完善的體內作用機制和生物分佈分析。

對於製藥公司、合約研究機構 (CRO) 和研究機構等買家而言，他們主要關注事項通常是影像品質、靈敏度、工作流程速度、定量和報告軟體、與探針和示踪劑的兼容性、服務支援以及系統運作整個生命週期的總成本。這個市場至關重要，因為良好的臨床前影像能夠降低早期研發階段的不確定性，並有助於避免後期研發過程中代價高昂的失敗。

臨床前影像市場動態

政府大力資助的生物醫學研究和大規模的臨床試驗計畫正在增加對臨床前影像資料的需求。

臨床前影像需求的成長主要受生物醫學研究經費增加和眾多藥物研發項目的推動。這些項目在進入成本高昂的臨床試驗階段之前，需要可靠的體內證據，尤其是在腫瘤學、神經科學和先進療法領域，生物分佈和反應監測至關重要。根據國家科學基金會(NSF) 預測，2022 年美國研發總支出將達到約 8,920 億美元，涵蓋實驗室營運、合約研究機構 (CRO) 營運和設備採購等研發活動。在醫療衛生領域，美國國立衛生研究院 (NIH) 2023 財政年度的預算授權約為 475 億美元，2024 財政年度約為 480 億美元，為大量的臨床前研究提供了支持。這些研究通常利用小動物影像進行時間序列分析。臨床開發平臺的規模也顯示臨床前影像需求持續存在。根據美國國家醫學圖書館 (NLM) 的 ClinicalTrials.gov 網站數據，2024-2025 年註冊的研究項目超過 50 萬項，顯示該領域研發管線十分龐大。許多專案在推進之前都需要藉助成像技術來概念驗證、標靶結合情況並收集安全性資料。這些公開數據顯示了市場上的促進因素：穩定的資金籌措和持續的研發管線活動，使得市場對成像系統、探針和軟體的需求持續成長，這些產品能夠提供可重複的結果、縮短研究時間並明確判斷是否繼續進行。

臨床前影像市場：細分分析

臨床前影像的需求與藥物開發平臺的運作和公共研究經費規模密切相關。管線越活躍，需要可測量的體內結果的動物研究就越多。臨床試驗註冊數量是衡量管線規模的便捷方法。根據美國國家醫學圖書館的ClinicalTrials.gov資料庫，2024年至2025年間註冊的研究超過50萬項，顯示全球藥物研發活動十分活躍，而這些研究通常需要在推進後續研究之前獲得可靠的臨床前資料包。研究層面的經費也支持類似的趨勢。根據美國國立衛生研究院（NIH）的數據，NIH 2023會計年度的預算約為475億美元，2024會計年度約為480億美元，這為腫瘤學、神經病學和感染疾病研究提供了廣泛的支持。這些領域經常利用小動物影像進行縱向追蹤和治療反應評估。歐洲也擁有廣泛的研發實力。根據歐盟統計局的數據，到 2022-2023 年，歐盟國內研發總支出將維持在 GDP 的 2% 以上，這將支持大學和研究機構對設備的持續需求。

研究技術需求也會影響採購決策。聯合影像工作流程的日益普及，尤其是那些需要同時進行結構細節分析、功能分析和分子分析的工作流程，正在推動對分析軟體的需求。基於示踪劑的研究依賴核醫學能力和同位素供應，這使得臨床前PET/SPECT活動與廣泛的核醫學基礎設施相連。預計到2020年代初期，各成員國的核醫學能力將擴展，核能（IAEA）報告稱，成像系統及相關基礎設施的安裝數量正在成長，這有助於構建分子成像工作流程所需的生態系統。同時，研究項目對一致性和文件記錄的要求不斷提高，推動了對能夠實現可重複掃描、高運轉率和標準化報告的系統的需求。在CRO（合約調查計畫）類型的環境中，這一點尤其重要，因為在這些環境中，研究的吞吐量和數據可比性至關重要。

臨床前影像市場—區域分析

臨床前影像活動通常在生物醫學研發經費充裕、擁有大規模大學和醫院研究網路以及強大的藥物開發平臺的地區最為活躍。這保證了對成像系統、探針和分析軟體的穩定需求。北美憑藉其龐大且穩定的公共研究預算，仍是一個重要的市場。根據美國國立衛生研究院 (NIH) 的數據，NIH 在 2023 會計年度的預算約為 475 億美元，在 2024 會計年度約為 480 億美元，用於支持腫瘤學、神經科學和感染疾病領域眾多以成像為核心的研究項目。歐洲的研究活動也保持強勁勢頭。根據歐盟統計局 (Eurostat) 的數據，預計 2022-2023 會計年度歐盟研發總支出將維持在 GDP 的 2% 以上，學術和政府研究機構將繼續購置設備併升級設施。研發管線的規模也是持續需求的指標之一。根據 ClinicalTrials.gov（美國國家醫學圖書館）的數據，預計 2024-2025 年將有超過 500,000 項研究註冊，這表明存在大規模的開發平臺，該管線依賴於臨床前數據和轉化生物標記研究。

美國臨床前影像市場—國家分析

美國是全球最大的單一市場，這得益於其雄厚的生物醫學研究經費基礎、許多活躍的研究機構，以及轉化研究與製藥、生物技術和受託研究機構（CRO）活動的緊密結合。其中，公共資金是最直接的促進因素。根據美國國立衛生研究院（NIH）的數據，2024會計年度的年度預算授權約為480億美元，這將支撐對小型動物影像平台及相關耗材的持續需求。更廣泛的研究環境也至關重要。根據國家科學基金會（NSF）的數據，2022年美國研發總支出將達到約8,920億美元，顯示高階設備和專業工作流程的需求強勁。藥物研發活動也帶來了額外的需求。根據ClinicalTrials.gov（美國國家醫學圖書館）的數據，2024年至2025年間將有超過50萬項研究註冊，這與臨床試驗前對基於影像的概念驗證、生物分佈研究和反應監測的持續需求相吻合。

目錄

第1章 臨床前影像市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 臨床前影像的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

4. 臨床前影像市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 臨床前影像市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：臨床前影像市場概況

  • 臨床前影像市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 按產品類型分類的臨床前影像市場

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 影像系統
    • 試劑/探針/造影
    • 軟體和服務

8. 依影像方式分類的臨床前影像市場

  • 概述
    • 細分市場佔有率分析：依治療方式
    • 光學成像
    • MRI
    • CT
    • PET
    • SPECT
    • 超音波
    • 光聲成像

9. 按應用分類的臨床前影像市場

  • 概述
    • 細分市場佔有率分析：按應用
    • 瘤
    • 神經系統疾病
    • 心臟病
    • 感染疾病
    • 其他

10. 按最終用戶分類的臨床前影像市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 製藥和生物技術公司
    • CRO（委外研發機構）
    • 學術和研究機構
    • 其他

11. 按地區分類的臨床前影像市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 主要供應商分析－臨床前影像產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Aspect Imaging Ltd.
    • BIONANO GENOMICS, INC.
    • Biospace Lab SA
    • Bruker Corporation
    • Canon Medical Systems Corporation
    • CubiX Imaging, Inc.
    • FUJIFILM VisualSonics Inc.
    • GE HealthCare Technologies Inc.
    • Mediso Ltd.
    • MILabs BV
    • MinFound Medical Systems Co., Ltd.
    • MR Solutions Group Ltd.
    • Nanoscan Imaging Ltd.
    • PerkinElmer Inc.
    • Philips International BV
    • Revvity, Inc.
    • Siemens Healthineers AG
    • Sofie Biosciences, Inc.
    • TriFoil Imaging, Inc.
    • Trifoil Imaging, Inc.
    • Others

第13章：分析師的全方位展望

簡介目錄
Product Code: ANV6068

Preclinical Imaging Market size was valued at US$ 995.98 Million in 2024, expanding at a CAGR of 5.54% from 2025 to 2032.

The preclinical imaging market includes the equipment, imaging agents, and software used to study diseases and drug effects in live animal models before human trials. These tools are important in early research because they allow repeated, non-invasive tracking of tumors, organs, or biological activity over time, which supports faster and more confident decisions in drug discovery. Common imaging options include micro-CT and micro-MRI for detailed anatomy, PET and SPECT for functional or molecular signals, and optical imaging for quick screening using fluorescent or bioluminescent probes, with many labs combining more than one method to improve study quality. Demand is linked to areas like oncology, neurology, and infectious disease research, plus the growth of biologics and advanced therapies that need better in vivo proof of mechanism and biodistribution.

For buyers such as pharma companies, CROs, and research institutes, the main focus is usually on image quality, sensitivity, workflow speed, software for quantification and reporting, compatibility with probes and tracers, service support, and the overall cost of running the system over its lifetime. This market matters because better preclinical imaging can reduce uncertainty earlier in development and help avoid expensive failures later in the pipeline.

Preclinical Imaging Market- Market Dynamics

Strong government-funded biomedical research and a large clinical pipeline are increasing the need for preclinical imaging data

Preclinical imaging demand is rising because more biomedical research funding and a large flow of drug programs require solid in vivo evidence before expensive clinical steps, especially for oncology, neuroscience, and advanced therapies, where biodistribution and response monitoring are critical. According to the U.S. National Science Foundation (NSF), total U.S. research and development spending reached about USD 892 billion in 2022, showing the overall scale of R&D activity that supports labs, CRO work, and equipment purchasing. In health-focused research, according to the National Institutes of Health (NIH), NIH budget authority was around USD 47.5 billion in FY2023 and about USD 48.0 billion in FY2024, which supports a large number of preclinical studies that often rely on small-animal imaging for longitudinal readouts. The size of the clinical development funnel also signals ongoing preclinical demand; According to ClinicalTrials.gov (U.S. National Library of Medicine), the registry listed more than 500,000 studies during 2024-2025, indicating a broad pipeline where many programs need imaging-backed proof-of-concept, target engagement, and safety support before moving forward. These public indicators point to a practical buying driver in the market: stable funding and steady pipeline activity create ongoing need for imaging systems, probes, and software that can deliver repeatable results, faster study timelines, and clearer go/no-go decisions.

Preclinical Imaging Market- Segmentation Analysis:

Preclinical imaging demand is closely tied to how busy the drug development pipeline is and how much public research funding is available, because higher activity creates more animal studies that need measurable in vivo results. A simple way to see the pipeline scale is through trial registration volume; according to ClinicalTrials.gov (U.S. National Library of Medicine), the database listed more than 500,000 studies during 2024-2025, which signals steady global development work that usually requires stronger preclinical packages before moving forward. Funding also supports the same trend at the research level; according to the National Institutes of Health (NIH), NIH budget authority was about USD 47.5 billion in FY2023 and around USD 48.0 billion in FY2024, keeping a large base of oncology, neurology, and infectious disease research active, where small-animal imaging is often used for longitudinal tracking and treatment response measurement. In Europe, broad R&D intensity has also been maintained; according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022-2023, which supports continued equipment demand from universities and research institutes.

Technology needs inside studies also shape buying decisions, especially when a study requires both structural detail and functional or molecular readouts, which pushes more combined imaging workflows and more demand for analysis software. Tracer-based work depends on nuclear medicine capacity and isotope supply, which connects preclinical PET/SPECT activity with wider nuclear medicine infrastructure. According to the International Atomic Energy Agency (IAEA), nuclear medicine capability expanded across member states through the early 2020s, supported by reported growth in installed imaging systems and related infrastructure, which helps build the ecosystem needed for molecular imaging workflows. Alongside this, stronger expectations around consistency and documentation in research programs are increasing demand for systems that can deliver repeatable scans, higher uptime, and standardized reporting, especially in CRO-style environments where throughput and data comparability across studies matter.

Preclinical Imaging Market- Geographical Insights

Preclinical imaging activity is usually strongest in regions with high biomedical R&D spending, large university and hospital research networks, and steady drug development pipelines, which keeps demand consistent for imaging systems, probes, and analysis software. North America remains important because public research budgets are large and stable; according to the National Institutes of Health (NIH), NIH budget authority was about USD 47.5 billion in FY2023 and about USD 48.0 billion in FY2024, supporting many imaging-heavy programs in cancer, neuroscience, and infectious disease. Europe also shows sustained research intensity; according to Eurostat, EU gross domestic expenditure on R&D stayed above 2% of GDP in 2022-2023, which supports continued equipment purchasing and facility upgrades in academic and government research institutes. Pipeline scale is another indicator of ongoing demand; according to ClinicalTrials.gov (U.S. National Library of Medicine), the registry listed more than 500,000 studies during 2024-2025, which signals a large development funnel that depends on preclinical evidence and translational biomarker work.

United States Preclinical Imaging Market- Country Insights

The United States is the strongest single-country market because the funding base for biomedical research is large, the number of active research organizations is high, and translational work is closely linked to pharma, biotech, and CRO activity. The most direct driver is public funding; according to the National Institutes of Health (NIH), annual budget authority stayed near USD 48 billion in FY2024, which supports continuous demand for small-animal imaging platforms and related consumables. The broader research environment is also large; according to the U.S. National Science Foundation (NSF), total U.S. spending on research and development reached about USD 892 billion in 2022, showing strong capacity for high-end instruments and specialized workflows. Drug development activity adds another demand layer; according to ClinicalTrials.gov (U.S. National Library of Medicine), registered studies exceeded 500,000 during 2024-2025, which aligns with ongoing needs for imaging-based proof-of-concept, biodistribution studies, and response monitoring before clinical commitments.

Preclinical Imaging Market- Competitive Landscape:

The preclinical imaging vendor landscape is usually discussed by modality strengths and workflow integration, because buyers tend to compare resolution, sensitivity, throughput, software quantification, and service support across platforms. Bruker Corporation is commonly referenced for preclinical MRI and micro-CT systems and integrated imaging workflows for research labs. Revvity, Inc. is frequently associated with optical imaging and reagent ecosystems used for fast in vivo screening and longitudinal monitoring. FUJIFILM VisualSonics Inc. is often linked to high-resolution preclinical ultrasound and photoacoustic imaging used in cardiovascular and oncology research. For nuclear imaging workflows, MILabs B.V. and Mediso Ltd. are typically cited for preclinical PET/SPECT systems and multi-modal configurations that support tracer-based studies. Larger imaging groups such as Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., and Canon Medical Systems Corporation are also referenced in the space due to strengths in imaging technology and software that support translational collaborations. Public demand signals explain why competition stays active; according to NIH and according to ClinicalTrials.gov (U.S. National Library of Medicine), the scale of research funding and the large pipeline of studies supports continued investment in higher-throughput systems, standardized analysis tools, and multi-modality imaging setups.

Recent Developments:

In October 2025, The START Center for Cancer Research, an oncology-focused clinical research organization, along with its preclinical division XenoSTART, and Minerva Imaging, a radiopharmaceutical CRO/CDMO specializing in molecular imaging and radionuclide therapy, expanded their long-running partnership to build an integrated platform for radiopharmaceutical drug development by combining clinically annotated patient-derived xenograft (PDX) models with advanced imaging capabilities such as PET/CT, SPECT/CT, and MRI plus GMP manufacturing, aiming to shorten timelines and reduce development risk for oncology radiopharmaceutical programs.

In September 2025, Revvity, Inc., a provider of health science solutions and preclinical imaging tools, launched Living Image(TM) Synergy AI, a multimodal in vivo imaging analysis software platform designed to unify data analysis across optical, microCT, ultrasound, and other modalities; the software adds AI-based automation for tasks such as image segmentation and ROI quantification to reduce manual work, improve throughput, and enhance reproducibility, and it was scheduled to be showcased at the WMIC conference in late September 2025.

In September 2023, Revvity, Inc., a supplier of preclinical imaging systems and workflow solutions, expanded its imaging portfolio with the launch of the next-generation IVIS(R) Spectrum 2 and IVIS SpectrumCT 2 optical imaging systems, the Quantum(TM) GX3 microCT solution, and the global debut of the Vega(R) ultrasound system, targeting higher sensitivity, resolution, and faster throughput for in vivo and ex vivo preclinical research workflows and presenting the systems at the World Molecular Imaging Congress (WMIC) in Prague.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRECLINICAL IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Aspect Imaging Ltd.
  • BIONANO GENOMICS, INC.
  • Biospace Lab S.A.
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • CubiX Imaging, Inc.
  • FUJIFILM VisualSonics Inc.
  • GE HealthCare Technologies Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • MinFound Medical Systems Co., Ltd.
  • MR Solutions Group Ltd.
  • Nanoscan Imaging Ltd.
  • PerkinElmer Inc.
  • Philips International B.V.
  • Revvity, Inc.
  • Siemens Healthineers AG
  • Sofie Biosciences, Inc.
  • TriFoil Imaging, Inc.
  • Trifoil Imaging, Inc.
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Imaging Systems
  • Reagents & Probes/Contrast Agents
  • Software & Services

GLOBAL PRECLINICAL IMAGING MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Optical Imaging
  • MRI
  • CT
  • PET
  • SPECT
  • Ultrasound
  • Photoacoustic Imaging

GLOBAL PRECLINICAL IMAGING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Diseases
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Others

GLOBAL PRECLINICAL IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical Imaging Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical Imaging Market Snippet by Product Type
    • 2.1.2. Preclinical Imaging Market Snippet by Modality
    • 2.1.3. Preclinical Imaging Market Snippet by Application
    • 2.1.4. Preclinical Imaging Market Snippet by End User
    • 2.1.5. Preclinical Imaging Market Snippet by Country
    • 2.1.6. Preclinical Imaging Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical Imaging Key Market Trends

  • 3.1. Preclinical Imaging Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical Imaging Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical Imaging Market Opportunities
  • 3.4. Preclinical Imaging Market Future Trends

4. Preclinical Imaging Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical Imaging Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Preclinical Imaging Market Landscape

  • 6.1. Preclinical Imaging Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical Imaging Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Imaging Systems
    • 7.1.3. Reagents & Probes/Contrast Agents
    • 7.1.4. Software & Services

8. Preclinical Imaging Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Optical Imaging
    • 8.1.3. MRI
    • 8.1.4. CT
    • 8.1.5. PET
    • 8.1.6. SPECT
    • 8.1.7. Ultrasound
    • 8.1.8. Photoacoustic Imaging

9. Preclinical Imaging Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Neurology
    • 9.1.4. Cardiology
    • 9.1.5. Infectious Diseases
    • 9.1.6. Others

10. Preclinical Imaging Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biotechnology Companies
    • 10.1.3. Contract Research Organizations (CROs)
    • 10.1.4. Academic & Research Institutes
    • 10.1.5. Others

11. Preclinical Imaging Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Preclinical Imaging Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Preclinical Imaging Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Preclinical Imaging Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Preclinical Imaging Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Preclinical Imaging Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Preclinical Imaging Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Aspect Imaging Ltd.
    • 12.2.2. BIONANO GENOMICS, INC.
    • 12.2.3. Biospace Lab S.A.
    • 12.2.4. Bruker Corporation
    • 12.2.5. Canon Medical Systems Corporation
    • 12.2.6. CubiX Imaging, Inc.
    • 12.2.7. FUJIFILM VisualSonics Inc.
    • 12.2.8. GE HealthCare Technologies Inc.
    • 12.2.9. Mediso Ltd.
    • 12.2.10. MILabs B.V.
    • 12.2.11. MinFound Medical Systems Co., Ltd.
    • 12.2.12. MR Solutions Group Ltd.
    • 12.2.13. Nanoscan Imaging Ltd.
    • 12.2.14. PerkinElmer Inc.
    • 12.2.15. Philips International B.V.
    • 12.2.16. Revvity, Inc.
    • 12.2.17. Siemens Healthineers AG
    • 12.2.18. Sofie Biosciences, Inc.
    • 12.2.19. TriFoil Imaging, Inc.
    • 12.2.20. Trifoil Imaging, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us